1. Home
  2. Live Updates
  3. மையங்கள் க்கு மருத்துவ உதவி மருத்துவ

மையங்கள் க்கு மருத்துவ உதவி மருத்துவ News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மையங்கள் க்கு மருத்துவ உதவி மருத்துவ. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மையங்கள் க்கு மருத்துவ உதவி மருத்துவ Today - Breaking & Trending Today

Renalytix Commends HHS/CMS on Finalization of MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices and Diagnostics


Home / Top News / Renalytix Commends HHS/CMS on Finalization of MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices and Diagnostics
Renalytix Commends HHS/CMS on Finalization of MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices and Diagnostics
Creates Pathway for Beneficiary Access to KidneyIntelX for Medicare Beneficiary Kidney Disease Populations
NEW YORK, Jan. 13, 2021 (GLOBE NEWSWIRE) The Centers for Medicaid & Medicare (CMS) announced the establishment of the Medicare Coverage of Innovative Technology (MCIT) pathway (
RIN: 0938-AT88), to provide a coverage pathway for Medicare beneficiaries nationwide to have faster access to new, innovative medical devices and diagnostic tests designated under the Breakthrough Device review program and with market authorization by the U.S. Food and Drug Administration (FDA). Under MCIT, national Medicare coverage can become effective on the date of FDA approval or clearanc ....

United States , Tom Mclain , Centers For Disease , Centers For Medicaid Medicare , Drug Administration , Medicare Coverage Of Innovative Technology , National Medicare , Creates Pathway , Beneficiary Access , Medicare Beneficiary Kidney Disease , Medicare Coverage , Innovative Technology , Breakthrough Device , Breakthrough Designation , Disease Control , ஒன்றுபட்டது மாநிலங்களில் , டோம் ம்கிலைன் , மையங்கள் க்கு நோய் , மையங்கள் க்கு மருத்துவ உதவி மருத்துவ , மருத்துவ பாதுகாப்பு ஆஃப் புதுமையானது தொழில்நுட்பம் , தேசிய மருத்துவ , உருவாக்குகிறது நடைபாதை , மருத்துவ பாதுகாப்பு , புதுமையானது தொழில்நுட்பம் , திருப்புமுனை சாதனம் , திருப்புமுனை பதவி ,

Investegate |Renalytix AI PLC Announcements | Renalytix AI PLC: Finalization of MCIT rule for coverage pathway


About RenalytixAI
RenalytixAI (LSE: RENX) (NASDAQ: RNLX) is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. The Company s lead product is KidneyIntelX.com (visit
www.kidneyintelx.com
) which is being designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery. For more information, visit
www.renalytixai.com
 
Forward-Looking Statements
Statements contained in this press release regarding matters that are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Examples of these forward-looking statements include statements concerning: the potential for Kidney ....

United States , Nicholas Moore , Paul Mcmanus Lianne Cawthorne , James Mccullough , Gary Clarence Daniel Adams , Tom Mclain , Centers For Disease , Drug Administration , Medicare Coverage Of Innovative Technology , Investec Bank , National Medicare , Exchange Commission , Centers For Medicaid Medicare , Rule To Provide National Medicare Coverage , Provide National Medicare Coverage , Beneficiary Access , Medicare Beneficiary Kidney Disease Populations , Medicare Coverage , Innovative Technology , Breakthrough Device , Breakthrough Designation , Nominated Adviser , Joint Broker , Disease Control , Private Securities Litigation Reform Act , Investegate Announcements ,